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Kisspeptin plays a critical role in pubertal timing and reproductive function. In rodents, kisspeptin
perikarya within the hypothalamic arcuate (ARC) and anteroventral periventricular (AVPV) nuclei
are thought to be involved in LH pulse and surge generation, respectively. Using bilateral micro-
injections of recombinant adeno-associated virus encoding kisspeptin antisense into the ARC or
AVPV of female rats at postnatal day 10, we investigated the relative importance of these two
kisspeptin populations in the control of pubertal timing, estrous cyclicity, and LH surge and pulse
generation. A 37% knockdown of kisspeptin in the AVPV resulted in a significant delay in vaginal
opening and first vaginal estrous, abnormal estrous cyclicity, and reduction in the occurrence of
spontaneous LH surges, although these retained normal amplitude. This AVPV knockdownhad no
effect on LH pulse frequency, measured after ovariectomy. A 32% reduction of kisspeptin in the
ARChadno effect on the onset of puberty but resulted in abnormal estrous cyclicity and decreased
LHpulse frequency.Additionally, theknockdownofkisspeptin in theARCdecreased theamplitude
but not the incidence of LH surges. These results might suggest that the role of AVPV kisspeptin
in the control of pubertal timing is particularly sensitive to perturbation. In accordance with our
previous studies, ARC kisspeptin signaling was critical for normal pulsatile LH secretion in female
rats.Despite thewidely reported roleofAVPVkisspeptinneurons in LH surgegeneration, this study
suggests that both AVPV and ARC populations are essential for normal LH surges and estrous
cyclicity. (Endocrinology 156: 2619–2631, 2015)
Kisspeptin (Kiss1) is essential for sexualmaturation be-cause inactivating mutations in Kiss1 (1) or its recep-
tor (Kiss1r) (2, 3) result in a lack of puberty and hypogo-
nadotropic hypogonadism, and activating mutations
cause precocious puberty (4, 5). Kisspeptin is the most
potent upstream stimulator of GnRH acrossmany species
(6–10) and is thought to act uponGnRHneurons directly;
most GnRH neurons express Kiss1r mRNA (11, 12) and
Kiss1 induces GnRH neuron c-Fos expression in rats
(10). Signaling through the GnRH neuron Kiss1r has
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been shown to be essential for puberty onset and fertility
(13, 14).
In rodents kisspeptin perikarya are located in the ar-
cuate (ARC) and anteroventral periventricular (AVPV)
hypothalamic nuclei, regions thought to have distinct
roles in kisspeptin-GnRH function. Unlike GnRH neu-
rons, both ARC and AVPV kisspeptin neurons express
estrogen receptor (ER)-, acting as relay afferents for es-
trogenic feedback upon the hypothalamus, positive feed-
back via the AVPV and negative via the ARC (15, 16).
AVPV neurons project onto and directly stimulate preop-
tic area (POA) GnRH neurons (11). In rodents, the AVPV
has a well-established role in LH surge generation; the
POA infusion of a kisspeptin-specific antibody blocks the
LH surge and represses estrous cyclicity, and kisspeptin
infusion can induce a surge equivalent of LH (17). Re-
cently kisspeptin has been shown to successfully induce an
LH surge and egg maturation in humans, with the poten-
tial for use in in vitro fertilization techniques (18).
ARC kisspeptin neurons are implicated in GnRH pulse
generation and are unique in that they coexpress neuro-
kinin B (NKB) and the opioid dynorphin A (Dyn) and are
thus denoted kisspeptin-NKB-Dyn (KNDy) neurons (19).
Oscillations of NKB and Dyn are thought to respectively
stimulate and inhibit KNDy neurons, driving the pulsed
release of kisspeptin, which acts in turn to drive pulses of
GnRH released at the median eminence (19). Axo-axonal
interactions may occur between GnRH and kisspeptin
neurons at the median eminence (20, 21), and kisspeptin
and GnRH release in this region have high temporal con-
cordance in rhesus monkeys (22). Kisspeptin administra-
tion has been shown to increase LH pulse frequency in
humans (23, 24), and infusion of a kisspeptin antagonist
into the median eminence suppresses GnRH pulses in fe-
male rhesusmonkeys (25). Intra-ARC administration of a
kisspeptin antagonist dose dependently reduces LH pulse
frequency in rats (26).Wehave recently shown that a 27%
reduction in ARC kisspeptin, using a similar protocol of
stereotactic injection of antisense kisspeptin in adult
Wistar rats,was sufficient to, albeitmodestly, significantly
decrease LH pulse frequency without affecting pulse am-
plitude (27). However, humans with severe inactivating
mutations inKISS1 orKISS1R retain very low amplitude,
although with normal frequency LH pulses (28, 29).
KISS1 may therefore amplify GnRH action, modulating
GnRH amplitude.
GnRH pulse amplitude and frequency increase over
puberty, stimulating gonadal maturation (30, 31). Kiss-
peptin antagonists can delay (32) and agonists advance
(33) puberty onset in rats. Over the pubertal transition,
LH minisurges occur in the afternoon, at approximately
the time of the adult surge, increasing in amplitude and
frequency until the first mature LH surge proper (34).
Estrogen-dependent maturation of AVPV Kiss1 gene ex-
pression (35), AVPV Kiss1mRNA and immunoreactivity
(7, 36, 37), AVPV Kiss1 promoter histone 3 acetylation,
recruitingER (38),GnRHneuronkisspeptin appositions
(39),Kiss1r expression (12), andGnRHneuron sensitivity
to kisspeptin (36) occur over puberty.
ARCKiss1mRNA increases over puberty in the rat and
mouse to a much lesser degree than AVPV Kiss1 mRNA
(35, 40, 41). However, increasing pulse generator fre-
quency is a key pubertal event in the rat (30, 40). Although
the roles of ARC and AVPV nuclei in LH surge and pulse
generation have been explored, whether it is ARC or
AVPV kisspeptin, which is essential for puberty onset is
unknown; their distinct roles in subsequent estrous cyclic-
ity have also not been directly investigated. So far, con-
genital cell ablation and gene knockout methods have
been used to study the necessity of kisspeptin in puberty.
Whole-body kisspeptin congenital ablation, kisspeptin
geneknockout, and specificGnRHneuronKiss1r deletion
methods have been used previously, with results respec-
tively interpreted as revealing functional compensation,
redundant overproduction of kisspeptin, or the necessity
of Kiss1r on the GnRH neuron for puberty, with some
conflicting results.
Large-scale gross knockdown methods do not allow
discernment of the regional actions of kisspeptin. In this
study we used microinjections of antisense kisspeptin
cDNA in a recombinant AAV-associated viral construct
(rAAV-kisspeptin-AS) bilaterally into either ARC or
AVPV nuclei of female Sprague Dawley rats on postnatal
day (pnd) 10, using rAAV-encoding enhanced green flu-
orescent protein (rAAV-EGFP) as a control. Unlike global
knockdownmodels, local injections allow discernment of
the regional actions of Kiss1 neurons; some physiological
function of kisspeptin is retained which, in combination
with injecting the rats at this age,minimizes potential con-
founding by functional developmental compensation.We
were therefore able to investigate the differential role of
ARC and AVPV kisspeptin signaling in pubertal timing,
estrous cyclicity, and LH surge and pulse generation.
Materials and Methods
Female Sprague Dawley rats, obtained from Charles River, fed
standard laboratory chow, and watered ad libitum, were bred
and housed with their litters under controlled conditions (tem-
perature, 21–23ºC, 12-hour light, 12-hour dark cycles with
lights on at 7:00 AM) until pnd 21 when the female pups were
weaned and housed in groups of three to four per cage. The body
weight of all female pupswasmeasured every 3 days fromwean-
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ing. All animal procedures were in accordance with the British
Home Office Animals Scientific Procedures Act 1986.
Antisense kisspeptin construct
RT-PCR isolated full-length Kiss1 cDNA was cloned into
pTR-CGW vector (from Dr J. Verhaagen, Netherlands Institute
for Neuroscience, Amsterdam, The Netherlands) with the am-
picillin resistance gene, inverted terminal repeats, human imme-
diate early cytomegalovirus promoter andwood chuckposttran-
scriptional regulatory element. The cytomegalovirus promoter
was reverse orientation, producing antisense cRNA. We have
previously shown the validity of this construct in inhibiting kiss-
peptin production (27). Both rAAV-kisspeptin-AS and rAAV-
EGFPwerepreparedusing theadenovirus-freemethoddescribed
previously (42) and rAAV was produced using the two-plasmid
system (plasmid pDG fromDr J. A. Kleinschmidt, German Can-
cer Research Center, Heidelberg, Germany). The kisspeptin-AS
corresponds to nucleotides 1–393 of sequenceNM-181692.Dot
blot assays were used to establish physical particle titer, and
infectious center assays were used to determine the infectious
particle titer.
Intranuclear injection
Surgery was performed at pnd 10 to allow 3 weeks for max-
imum expression of kisspeptin-AS to be achieved before puberty
onset (27, 42, 43). Surgical procedures were performed under
aseptic conditions, using general anesthesia (ketamine hydro-
chloride USP; 100 mg/mL; Phizer Ltd) and Rompun (10 mg/kg;
Bayer AG) via ip injection. The animal was secured in a David
Kopf stereotaxic frame. Using a 2-L Hamilton microsyringe
(Sigma-AldrichLtd),with a glass needle connected to its tip, 1L
of rAAV-kisspeptin-AS or rAAV-EGFP containing 5 1012 ge-
nome particles were infused into either the ARC or the AVPV
nucleus over 10minutes, via aburr hole (FFXC7HPburr;Wright
Dental Group Ltd) drilled into the skull overlying the ARC or
AVPV nucleus. The needle was left in place for 5 minutes and
then removed slowly over 1 minute and the procedure repeated
for the contralateral nucleus. The respective coordinates for the
ARCandAVPV (0.38mm lateral, 2.60mmposterior to bregma,
7.30mmbelowthe surfaceof thedura, and0.38mmlateral, 0.18
mm anterior to bregma, 6.10 mm below the surface of the dura)
were used after careful verification in preliminary experiments
and dye injection sites in brain sections of pnd 10 rats, targeting
the ARC and AVPV using initial coordinates 0.50 mm lateral,
3.30mmposterior to bregma, 10.50mmbelow the surface of the
dura, and 0.20 mm lateral, 0.26 mm posterior to bregma, 8.60
mm below the surface of the dura, respectively, as per the adult
rat atlas (44) to establish coordinates for the smaller animals.
At 3 weeks after injection of rAAV-EGFP into the ARC or
AVPV, a subset of rats (n  5 per group) was killed, brains
removed, and stored at 80ºC. Forty-micrometer coronal sec-
tions were cut and mounted on polylysine slides. The brain sec-
tions were rehydrated, coverslipped, and viewed by direct fluo-
rescence using a microscope (Nikon A1R Si Confocal; Nikon).
Puberty onset and estrous cycles
Animalsweremonitored for vaginal opening and first vaginal
estrus (markers of puberty onset) between 9:00 and 10:00 AM
daily from pnd 28. Once vaginal opening occurred, vaginal
smears were taken daily for 2–3 consecutive weeks to detect the
stage of the estrous cycles. Normal estrous cyclicity was defined
as having at least two consecutive normal cycles,which lasted for
4–5 days with 1–2 days of estrus. Cycle length, with three stages
observed in the correct order, was determined by the number of
days between each occurrence of estrus.
Blood sampling to detect LH and estradiol levels
Approximately 7 days after puberty, the rats were implanted
with two indwelling cardiac catheters via the jugular veins to
enable blood sampling for LH and estradiol measurement. The
catheters were exteriorized at the back of the head and secured
to a cranial attachment (40); the rats were fitted with a 30-cm-
long metal spring tether (Instec Laboratories Inc), the distal end
of which was attached to a fluid swivel (Instec Laboratories),
allowing the rat free movement. After iv catheterization, rats
were housed individually and blood sampling commenced about
3 days later.
LH surge
For spontaneous LH surge detection approximately 10 days
after puberty onset, once confirmed by vaginal smear to be in the
proestrous cycle stage, the rats were connected by one of the two
cardiac catheters to a computerized automatic blood sampling
system. Half-hourly blood sampling began at 11:30 AM for 8
hours. At every 25-L blood withdrawal, 25 L of heparinized
saline (50U/mL heparin sodiumnormal saline (Wockhardt) was
infused into the rat to keep the catheter patent and restore blood
volume. Manual blood samples (250 L) were collected via the
second catheter at 12:00 PM for estradiol measurement. Blood
samples were frozen at20ºC for later LH and estradiol assay.
LH pulses
After the blood sample collection for the detection of the
spontaneous LH surge, rats were ovariectomized (OVX) (45) to
facilitate LH pulse detection. After a 10-day recovery period,
they underwent automated blood sampling for LH pulse fre-
quency, starting at 10:00 AM, sampling every 5 minutes for 6
hours. The animals were then killed and tissues collected.
Quantification of ARC and AVPV kisspeptin and
ARC NKB
Animals were decapitated on pnd 50–60 and brains rapidly
removed and snap frozen in isopentane and stored at 80ºC.
Coronal sections (300 m) were cut on a cryostat, and punches
(1 mm diameter) of these serial sections of the ARC and AVPV
were taken from bregma 1.7 to 3.9 mm and 0.2 to 0.4
mm, respectively, according to the rat brain atlas (44), after the
micropunch method of Palkovits (46). The punched tissue was
homogenized in an acid-ethanol extraction buffer (0.15% hy-
drochloric acid in 25%ethanol) and analyzed for the quantity of
kisspeptin by specific kisspeptin RIA using 1.5  105 dilution
Millipore kisspeptin rabbit polyclonal antibody (Millipore)
raised tokisspeptin-10 and125I-labeledkisspeptin-10 (Advanced
Biotechnology Centre, Imperial College London, London,
United Kingdom) as described previously (27, 47) (see Table 1).
All assays used 350 L of phosphate buffer (pH 7.4) with 0.3%
BSA and 0.02% Tween 20 and had 3 days of incubation. The
smallest detectable limit for the assays was 1 fmol/punch. NKB
was quantified in punched ARC tissue from intra-ARC rAAV-
kisspeptin-AS- and control rAAV-EGFP-injected animals, using
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an ELISA kit following the manufacturer’s instructions (Penin-
sula Laboratories LLC).
RIA for LH and estradiol
A double-antibody RIA supplied by the National Institute of
Diabetes andDigestive and KidneyDiseases (Bethesda,Maryland)
was used to determine the LH concentration in the 25-L whole-
blood sample. Reference preparation was rat Luteinizing Hor-
mone-Reference Preparation-3 (rLH-RP-3). The sensitivity of the
assaywas 0.093 ng/mL. The intraassay coefficient of variationwas
5.3% and the interassay coefficient of variation was 7.5%. A dou-
ble-antibody RIA (ImmuChem; MP Biomedicals) was used to es-
timatetheestradiolcontentoftheplasmasamples(50L)following
themanufacturer’s protocol.The intraassay coefficient of variation
was 10.2%. All samples were analyzed on single determinations.
Statistical analysis
All data are presented as the mean  SEM. The effect of
rAAV-kisspeptin-AS on LH surges was determined by analyzing
the area under the LH profile curve (AUC). The algorithm
ULTRA was used to establish the detection of LH pulses (48).
Two intraassay coefficients of variation of the assaywere used as
the reference threshold for the pulse detection. The effect of
rAAV-kisspeptin-AS on pulsatile LH secretion was analyzed by
comparing themean LH pulse interval over the 6-hour sampling
period. A Student’s t test was used to analyze kisspeptin immu-
noreactivity and NKB levels. A Fisher’s test was used to analyze
the percentage of rats spontaneously exhibiting an LH surge in
proestrus and for analysis of estrous cyclicity. All other results
were analyzed by a one-way ANOVA (Systat Software). P .05
was considered significant.
Results
Anatomical localization of enhanced green
fluorescent protein (EGFP) after ARC or AVPV
injection
After intra-ARCor intra-AVPV rAAV-EGFP injection,
EGFP-containing cell bodies and axons were observed at
high density within the ARC and AVPV, respectively,
without spread to surrounding hypothalamic nuclei (Fig-
ure 1, A–D). Some slight expression of EGFP was also
observed in the injection tracts. Critically, for the intra-
ARC- or intra-AVPV rAAV-EGFP-injected animals, no
EGFP-containing neurones were observed in the corre-
sponding AVPV or ARC, respectively (Figure 1, A–D).
Effect of rAAV-kisspeptin-AS on ARC and AVPV
kisspeptin immunoreactivity (IR) and ARC levels of
NKB
Intra-ARCand intra-AVPV rAAV-kisspeptin-AS injec-
tions both resulted in significant reductions in kisspeptin
immunoreactivity (IR), validated and quantified by mi-
cropunch collection and RIA. Intra-ARC rAAV-kisspep-
Table 1. Information About Antibodies Used
Peptide
Target
Antigen
Sequence
Name of
Antibody
Manufacturer,
Catalog
Number,
and/or Name
of Individual
Providing the
Antibody
Species Raised
(Monoclonal or Polyclonal)
Dilution
Used
Kisspeptin 10 YNWNSFGLRY-NH2 Antikisspeptin Millipore, AB9754 Rabbit, polyclonal 1:1.5  105
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Figure 1. Effect of intra-ARC and intra-AVPV administration of rAAV-
kisspeptin-AS or rAAV-EGFP in female rats. Representative images
showing rAAV-EGFP spread in the AVPV (A) and ARC (B) after intra-
AVPV administration are shown. Representative images showing rAAV-
EGFP spread in the AVPV (C) and ARC (D) after intra-ARC
administration are also shown. 3V, third ventricle; VMH, ventromedial
hypothalamus. Scale bars represent 100 m (A and C) and 200 m (B
and D), respectively. E and F, The effect of intra-AVPV or intra-ARC
rAAV-EGFP and rAAV-kisspeptin-AS administration (on pnd 10) on
kisspeptin-IR in the AVPV and ARC, respectively. Quantification of
kisspeptin-IR in the AVPV and ARC was carried out between pnd 50
and pnd 60 by a RIA (n  7–9 per group). Data are shown as means 
SEM. *, P  .05.
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tin-AS caused a 32.0% knockdown in ARC kisspeptin-IR
vs control rAAV-EGFP rats [39.4 3.7 (ARC rAAV-kiss-
peptin-AS; n  7) vs 57.9  4.9 (ARC rAAV-EGFP; n 
8) fmol/punch, P  .05, Figure 1F]. Intra-AVPV rAAV-
kisspeptin-AS resulted ina36.5%reduction inAVPVkiss-
peptin-IR vs rAAV-EGFP controls [8.1 0.8 (rAAV-kiss-
peptin-AS; n  7) vs 12.8  1.5 (rAAV-EGFP; n  9)
fmol/punch, P .05, Figure 1E]. As an additional control
for potential cross-contamination between the injection
sites in the ARC and AVPV, the effects of intra-ARC or
intra-AVPV rAAV-kisspeptin-AS injections on kisspep-
tin-IR in the opposite nucleus to where the virus was in-
jected were examined and shown to have no affect com-
pared with the respective rAAV-EGFP controls (ARC
content after intra-AVPV rAAV-kisspeptin-AS: 68.3 
8.4 fmol/punch, n 6, P .05; AVPV content after intra-
ARC rAAV-kisspeptin-AS: 16.0 1.2 fmol/punch, n 6,
P  .05). Intra-ARC administration of rAAV-kisspep-
tin-AS had no significant effect on ARC-NKB content
comparedwith rAAV-EGFP control [31.36.5pg/punch
(rAAV-EGFP) vs 27.6 4.8 pg/punch (rAAV-kisspeptin-
AS; n  6–7), P  .05].
Effect of rAAV-kisspeptin-AS on
female rat puberty
Intra-ARC rAAV-kisspeptin-AS
did not significantly alter the day
of vaginal opening compared with
ARC rAAV-EGFP controls [37.2 
0.9 (ARC rAAV-kisspeptin-AS; n 
7) vs 36.7 0.6 (ARC rAAV-EGFP;
n  8) postnatal days, P  .68, Fig-
ure 2A] or the day of first vaginal
estrus [37.3 0.7 (ARC rAAV-kiss-
peptin-AS; n  9) vs 37.5  1.0
(ARC rAAV-EGFP; n 7) postnatal
days, P  .86]. There was no signif-
icant difference between gross body
weight gain between ARC rAAV-
kisspeptin-AS rats and controls
(Figure 2B).
There was a significant delay in
the day of vaginal opening after in-
tra-AVPV rAAV-kisspeptin-AS ad-
ministration compared with AVPV
rAAV-EGFP controls [40.2  0.9
(AVPV rAAV-kisspeptin-AS; n  7)
vs 36.8  1.0 (AVPV rAAV-EGFP;
n  8) postnatal days, P  .05, Fig-
ure 2C]. Intra-AVPV rAAV-kisspep-
tin-AS also caused a significant delay
indayof first vaginal estrus vs rAAV-
EGFP controls [41.0  0.9 (AVPV
rAAV-kisspeptin-AS; n 7) vs 37.2 1.0 (AVPV rAAV-
EGFP; n 9) postnatal days, P .05]. Gross bodyweight
gain did not vary significantly between AVPV rAAV-kiss-
peptin-AS rats and controls (Figure 2D).
Effect of rAAV-kisspeptin-AS on ovarian cyclicity
Daily vaginal cytology frompuberty onset until the rats
were ovariectomized revealed a significant reduction in
the percentage of normal estrous cycles after both ARC
and AVPV rAAV-kisspeptin-AS administration. Intra-
ARC rAAV-kisspeptin-AS injected rats compared with
rAAV-EGFP controls had significantly fewer normal es-
trous cycles [percentage of normal estrous cyclicity
(28.5% [ARC rAAV-kisspeptin-AS; n  7] vs 87.5%
[ARC rAAV-EGFP; n  8] P  .05, Figure 3A]. Repre-
sentative examples of typical estrous cyclicity areprovided
(Figure 3B, ARC rAAV-EGFP, and Figure 3C, ARC
rAAV-kisspeptin-AS). Cycle length was also prolonged
(Figure 3D; P  .05) with an increase in estrus and de-
crease in diestrous phases evident in intra-ARC rAAV-
kisspeptin-AS-treated animals (Figure 3E; P  .05).
Normal estrous cyclicity was also significantly reduced
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Figure 2. The effect of intra-ARC and intra-AVPV rAAV-kisspeptin-AS administration on day of
vaginal opening and body weight in rats. A, No significant delay was observed in day of vaginal
opening in intra-ARC rAAV-kisspeptin-AS vs intra-ARC rAAV-EGFP controls. B, Body weight did
not vary significantly between ARC rAAV-kisspeptin-AS and ARC rAAV-EGFP. C, There was a
significant delay in day of vaginal opening after intra-AVPV rAAV-Kisspeptin-AS compared with
intra-AVPV rAAV-EGFP controls. D, Body weight did not vary significantly between AVPV rAAV-
kisspeptin-AS and AVPV rAAV-EGFP. Results are presented as means  SEM. *, P  .05 vs rAAV-
EGFP controls (means  SEM; n  7–9 per group).
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in intra-AVPV rAAV-kisspeptin-AS
rats compared with rAAV-EGFP
controls during the experimental pe-
riod [percentage of normal estrous
cyclicity (14.2% [AVPV rAAV-kiss-
peptin-AS; n  7] vs 78.0% [AVPV
rAAV-EGFP; n 9], P .05, Figure
3F]. Examples of typical estrous
cyclicity are provided (Figure 3G,
AVPV rAAV-EGFP, and Figure
3H, AVPV rAAV-kisspeptin-AS).
Intra-AVPV rAAV-kisspeptin-AS simi-
larly significantly extended cycle length
(Figure 3I; P .05) with an increase in
estrus and decrease in diestrous phases
evident (Figure 3J; P .05).
Effect of rAAV-kisspeptin-AS on
spontaneous LH surges
To assess LH surge regularity, the
percentage of rats exhibiting an LH
surge on the day of proestruswas an-
alyzed for each experimental group.
Spontaneous LH surges were de-
tected in most control rats on the
day of proestrous; no significant
reduction was found in ARC rAAV-
kisspeptin-AS animals vs ARC rAAV-
EGFPcontrols [71.4%(ARCrAAV-ki-
sspeptin-AS; n  7) vs 83.3% (ARC
rAAV-EGFP; n 6) P .61, Figure
4F]. However, an AUC analysis
showed a significant decrease in LH
surge amplitude after ARC rAAV-kiss-
peptin-AS administration [2680.84 
457.09 (ARC rAAV-kisspeptin-AS;
n  5) vs 4814.47  733.10 (ARC
rAAV-EGFP; n  5) ng/mL  min,
P .05, Figure 4C]. Representative
examples of ARC rAAV-EGFP
control (Figure 4A) and rAAV-kiss-
peptin-AS (Figure 4B) LH surges
are included. Estradiol levels mea-
sured on the same proestrous day as
the detection of the LH surge were
significantly decreased in the ARC
rAAV-kisspeptin-AS rats [23.9 
2.4 (ARC rAAV-kisspeptin-AS;
n  7) vs 34.1  4.0 (ARC rAAV-
EGFP; n  6) pg/mL, P  .05].
Representative examples of AVPV
rAAV-EGFP (Figure 4D) and rAAV-
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Figure 3. The effect of intra-ARC and intra-AVPV rAAV-kisspeptin-AS administration on estrous
cyclicity in juvenile rats. Cyclicity was determined by analyzing daily vaginal cytology from day of
vaginal opening to ovariectomy. A, ARC rAAV-kisspeptin-AS resulted in a significant decrease in
percentage of normal estrous cyclicity vs rAAV-EGFP controls. Representative examples of estrous
cyclicity are presented for ARC rAAV-EGFP (B) and ARC rAAV-kisspeptin-AS (C) rats. D, Cycle
length was significantly extended after intra-ARC rAAV-kisspeptin-AS vs intra-ARC rAAV-EGFP
controls. E, Time spent in proestrous, estrous, and metestrous stages was extended, whereas
time spent in diestrus was decreased by ARC rAAV-kisspeptin-AS compared with controls. F,
AVPV rAAV-kisspeptin-AS also resulted in a significant decrease in percentage of normal estrous
cyclicity vs rAAV-EGFP controls. Representative examples of estrous cyclicity are presented for
AVPV rAAV-EGFP (G) and AVPV rAAV-kisspeptin-AS (H) rats. I, Intra-AVPV rAAV-kisspeptin-AS
also significantly extended the cycle length compared with intra-AVPV rAAV-EGFP. J, Intra-AVPV
rAAV-kisspeptin-AS did not significantly extend the percentage of time spent in proestrus
compared with AVPV rAAV-EGFP. Both estrous and metestrous cycle stages were prolonged
after AVPV rAAV-kisspeptin-AS vs AVPV rAAV-EGFP. AVPV rAAV-kisspeptin-AS reduced time
spent in diestrus. Results are presented as means  SEM. *, P  .05 vs rAAV-EGFP controls
(means  SEM; n  7–9 per group).
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kisspeptin-AS (Figure 4E) proestrous LH profiles are in-
cluded.For theAVPVrAAV-kisspeptin-ASgroup, the rep-
resentative profile demonstrates an absence of an LH
surge (Figure 4E) because only one of the seven rats as-
sessed exhibited a surgeonproestrus; this is reflected in the
significant percentage reduction in LH surge regularity
induced after the AVPV rAAV-kisspeptin-AS injection
compared with the rAAV-EGFP controls [14.3% (AVPV
rAAV-kisspeptin-AS; n  7) vs 77.8% (AVPV rAAV-
EGFP; n9)P .05, Figure 4F]. Therewas no significant
difference between ARC and AVPV control LH surge
AUC analyses, which were compa-
rable in size with the one LH surge
exhibited among the AVPV rAAV-
kisspeptin-ASgroup.Estradiol levels
measured on the same proestrous
dayasdetectionof theLHsurgewere
significantly decreased in the AVPV
rAAV-kisspeptin-AS rats [20.8 
2.6 (AVPV rAAV-kisspeptin-AS;
n  7) vs 38.3  3.5 (AVPV rAAV-
EGFP; n  9) pg/mL, P  .05].
Effect of rAAV-kisspeptin-AS on
pulsatile LH release in adult
OVX rats
Regular LH pulses were detected
in all OVX experimental groups.
Representative LH profiles illustrat-
ing the effect of intra-ARC rAAV-
EGFP (Figure 5A) and intra-ARC
rAAV-kisspeptin-AS (Figure 5B) are
included. OVX rats administered in-
tra-ARC rAAV-kisspeptin-AS had
significantly longer LH pulse inter-
vals compared with ARC rAAV-
EGFP controls [27.1  0.6 (ARC
rAAV-kisspeptin-AS; n  7) vs
24.9  0.5 (ARC rAAV-EGFP; n 
8) min, P  .05, Figure 5C]. Repre-
sentative LH profiles for animals ad-
ministered intra-ARC rAAV-EGFP
(Figure 5D) and intra-ARC rAAV-
kisspeptin-AS (Figure 5E) are included.
Intra-AVPV rAAV-kisspeptin-AS ani-
mals exhibited no significant difference
inLHpulse intervalsvscontrols [26.4
0.8 (AVPVrAAV-kisspeptin-AS;n7)
vs25.30.7 (AVPVrAAV-EGFP;n
9) min, P  .31, Figure 5F]. LH pulse
amplitudewasnot affected in any treat-
ment group (data not shown).
Discussion
This is the first study to use intranuclear injections of an-
tisense kisspeptin in juveniles to evaluate the distinct, re-
gional roles of ARC vs AVPV kisspeptin in puberty and
reproductive function. By knocking down but not com-
pletely ablating kisspeptin expression from pnd 10, some
physiological function is preserved, and the potentially
confounding effects of developmental compensation or
redundancy are limited. Stereotactically injected rAAV-
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Figure 4. The effect of intra-ARC and intra-AVPV rAAV-kisspeptin-AS administration on LH
surges in rats. Representative LH surges after intra-ARC rAAV-EGFP (A) and intra-ARC rAAV-
kisspeptin-AS (B) are shown. C, AUC analysis of LH surges after intra-ARC rAAV-kisspeptin-AS vs
control intra-ARC rAAV-EGFP revealed a significant decrease after ARC kisspeptin knockdown.
Representative LH surge for intra-AVPV rAAV-EGFP (D) and the absence of an LH surge (E) after
intra-AVPV rAAV-kisspeptin-AS administration are also shown. F, Intra-AVPV rAAV-kisspeptin-AS
significantly decreased proestrous LH surge incidence vs intra-AVPV rAAV-EGFP controls; only
one of seven rats exhibiting a normal LH surge occurring on proestrus. There was no significant
difference in incidence of LH surges occurring on proestrus after intra-ARC rAAV-kisspeptin-AS vs
intra-ARC rAAV-EGFP controls (F). Results are presented as means  SEM. *, P  .05 vs rAAV-
EGFP controls (means  SEM; n  5–9 per group).
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kisspeptin-AS resulted in a 37%knockdownofAVPVand
32% reduction of ARC kisspeptin content, comparable
with that found using this methodology in adult Wistar
rats (27).
AVPV injection of rAAV-kisspeptin-AS delayed day of
vaginal opening and first estrus by an average 3.4 and 3.8
days, respectively. There was no effect of ARC knock-
down on either measure, despite the close association of
puberty with increasing pulse generator frequency in rats
(30, 40). Neither experiment was confounded by changes
in body weight, a critical factor in pubertal timing in ro-
dents. Although both vaginal opening and first estrus are
surrogate end point measurements, vaginal opening sig-
nifies the rising estrogen levels nec-
essary for puberty initiation, and
first vaginal estrus indicates com-
plete hypothalamic-pituitary-go-
nadal (HPG) axis maturation (49).
Given the estrogenic nature of these
markers, the known role of estrogen
in the maturation of AVPV kisspep-
tin over puberty (7, 12, 35–39), the
increases in AVPV Kiss1 expression
that occur before puberty in mice
(41), the lack of significant ARC
kisspeptin pubertal maturation (33,
37), and the role of AVPV kisspeptin
in estrogen-positive feedback upon
GnRHneurons (15), it is perhapsun-
surprising that it is AVPV and not
ARC kisspeptin that appears to be
fundamental for puberty onset.
However, it is possible that the ARC
knockdown stimulates a greater de-
gree of compensation than AVPV or
that AVPV-derived Kiss1 present in
the ARC (39) plays a significant role
or that the residual function remain-
ing after ARC rAAV-kisspeptin-AS
is sufficient for maintaining puberty
onset, although the abnormal cyclic-
ity and LH pulse data observed after
the ARC rAAV-kisspeptin-AS ad-
ministration suggest that the magni-
tude of knockdownachieved can sig-
nificantly influence the HPG axis.
Although the effect of ARC rAAV-
kisspeptin-AS administration on
pulse interval in OVX rats is rela-
tively small, it is possible that it
would result in larger effects in intact
rats.
Whole-body congenital ablation of most Kiss1/Kiss1r-
expressing cells failed to significantly impact puberty tim-
ing, estrous cyclicity, basal LH, or subsequent fertility in
mice. However, carrying out such an ablation at pnd 20
did have a significant impact on puberty and fertility (50).
This suggests that if the insult occurs early enough, func-
tional compensatory mechanisms may restore the deficit,
safeguarding reproductive function. Whole-cell ablation
removes all other signaling molecules produced by that
cell and may therefore trigger a greater level of compen-
sation than other knockout methods. Multiple redundan-
ciesmay further safeguard fertility. It has been shown that
only 34% of GnRH is essential for LH surges and suc-
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Figure 5. The effect of intra-ARC and intra-AVPV rAAV-kisspeptin-AS on pulsatile LH release in
OVX female rats. Representative LH profiles illustrating the effect of intra-ARC rAAV-EGFP (A)
and intra-ARC rAAV-kisspeptin-AS (B) are shown. C, Intra-ARC rAAV-kisspeptin-AS significantly
increased LH pulse interval compared with ARC rAAV-EGFP controls. Representative LH profiles
illustrating the effect of intra-AVPV rAAV-EGFP (D) and intra-AVPV rAAV-kisspeptin-AS (E) are
also shown. F, LH pulse interval was not significantly altered by intra-AVPV rAAV-kisspeptin-AS
compared with rAAV-EGFP controls. Results are presented as means  SEM. *, P  .05 vs rAAV-
EGFP controls (means  SEM; n  8–9 per group).
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cessful ovulation in mice (51). Knockdown of 95% of
kisspeptin expression had no significant impact on pu-
berty onset, estrous cyclicity, or basal LH in mice, al-
though fecundity was reduced (52). Therefore, either only
5% of murine kisspeptin is necessary for full HPG axis
function or there is compensation, for instance via NKB,
glutamate or increasing GnRH neuron sensitivity to the
remaining kisspeptin over time (52). These results may
also simply reflect the general sensitivity of the Kiss1r to
even low levels of kisspeptin (36).
In contrast, a previousKiss1/Kiss1rmouse gene knock-
out did report delayed vaginal opening, absent estrous
cycles, and infertility (53); the greater degree of gene
knockout and the reported heightened GnRH response to
kisspeptin could explain the discrepancy in their results
and support the hypothesized role of compensation. Two
studies have recently shown that kisspeptin signaling
through Kiss1r on the GnRH neuron is essential for re-
productive function; GnRH neuron-specific deletion of
the Kiss1r resulted in absent puberty over the 6-month
experimental period, no estrous cyclicity, and infertility
(13). A 64% reduction in murine GnRH neuron Kiss1r
resulted in delayed day of vaginal opening, abnormal es-
trous cyclicity, infertility, and reduced basal LH (14). This
relationship is causal because the phenotype was reversed
on reinstatement of the Kiss1r (13).
Puberty halts in ER knockout mice before first estrus
(54). In line with our results, an estrogen-dependent am-
plification mechanism may therefore exist, stimulating
GnRH neurons, via ER on AVPV kisspeptin neurons, to
reach a mature state. Specific prepubertal ARC estrogen-
inhibition, preventingGnRHpulse generation and gonad-
otropin production in the juvenile period,may be lifted by
increasing activation of GnRH neurons via AVPV kiss-
peptin (55). The estrogen/kisspeptin-independent trigger
driving this activation is unknown; glutamate, -ami-
nobutyric acid (GABA), and epigenetic regulation of poly-
comb group genes Eed and Cbx7 are currently being in-
vestigated (56, 57). Repeats of our methodology using
antisense ER, glutamate, GABA, and regulators such as
neuropeptide Y inter alia, may provide information re-
garding the hierarchy of action, the role of critical win-
dows (56), and the time line for this process.
There is a general shift from inhibition to stimulation of
GnRH neurons over puberty, via changes in GABA, glu-
tamate, and kisspeptin signaling as well as glial cell inter-
actions (58–60). GABA and glutamate are also compo-
nents of a complex interplay between KNDy neurons and
other potential afferents acting upon GnRH dendrons or
at the median eminence to stimulate coordinated pulsed
secretions of GnRH. Where ARC kisspeptin stimulation
sits and its hierarchical importance within this is not fully
understood. Individually knocking down these alternative
regulators using ourmethodologymayalso aid the piecing
together of the control mechanisms of pulse generation.
Both normalGnRH/gonadotropin surge (32) and pulse
(26) generation, supported via Kiss1-Kiss1r signaling in
theAVPVandARC, respectively, arenecessary fornormal
estrous cyclicity. In accord with this, we found abnormal
cycles in both rAAV-kisspeptin-AS groups. In both the
ARC and AVPV groups, rAAV-kisspeptin-AS extended
cycle length, inparticular increasing thepercentageof time
spent in the estrous and metestrous stages, whereas time
spent in diestrus was approximately halved across both
experimental groups. Lapatto et al (53), Popa et al (52),
and Mayer and Boehm (50) report cycles with some pro-
longed estrous-phase vaginal cornification, implying es-
trogenic stimulation has occurred (29) at a level insuffi-
cient for complete cycles of folliculogenesis and ovulation,
reflected in the absent/reduced corpora lutea counts in the
former two studies. Kiss1//Kiss1r/ mice (29) and
kisspeptin ER knockout mice (54) move between the es-
trous and diestrous phases but remain anovulatory.
GnRH knockdown mice enter puberty but are incapable
of producing an LH surge, are consequently anovulatory,
and fail to exhibit estrous cycles (51). Taken with our
results, these studies suggest that somebasal gonadotropin
secretion remains in Kiss1/Kiss1r knockout mice, permit-
ting incomplete rounds of folliculogenesis in which the
animals get stuck in cornifiedpreovulatoryphases because
the estrogen-kisspeptin-GnRH stimulus essential for ovu-
lation is inhibited (29, 53). Our data indicate that a high
level of such stimulation is required because approxi-
mately 35% of kisspeptin knockdown in either ARC or
AVPV nuclei resulted in kisspeptin levels insufficient for
normal cyclicity. The lack of spread of the viral vector
between the injection sites in the ARC and AVPV and the
lack of change in kisspeptin-IR in the opposite nucleus to
where the virus was injected suggests that there is unlikely
to be any significant cross-contamination between these
key kisspeptin-containing nuclei.
Our AVPV data are in keeping with the loss of estrous
cyclicity described after POA lesioning (61, 62) and POA
kisspeptin antagonist administration (17). Similarly our
ARC results correlate with the prolonged estrous cycles
found after ARC lesioning (63) and the disruption in cy-
clicity we described after rAAV-kisspeptin-AS in adult rat
ARC nuclei (27). Increased LH interpulse interval caused
by ARC rAAV-kisspeptin-AS may have impaired tonic
release of gonadotropins and folliculogenesis, and the in-
hibition of LH surges after both ARC and AVPV rAAV-
kisspeptin-AS may have prevented normal ovulation.
LH surges are conventionally associated with AVPV
kisspeptin and can be reliably generated using estrogen in
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OVX mice, which stimulates c-FOS expression in GnRH
and AVPV kisspeptin neurons. This does not occur in
Kiss1 and Kiss1r null mice (64, 65). LH surges were mea-
sured in gonadally intact animals and so are as precise a
measurement of spontaneous surge activity as possible.
Only one rat in the AVPV rAAV-kisspeptin-AS group ex-
hibited an LH surge correctly occurring on proestrus,
which was of normal amplitude. In the ARC knockdown
group, all rats had LH surges occurring with normal in-
cidence on proestrus but with significantly attenuated
amplitudes.
AVPV neurons have connections with ipsilateral argi-
nine vasopressin neurons in the suprachiasmatic nucleus,
implicated in circadian timing (66, 67). In rats the LH
surge occurs in the afternoon of proestrus. The circadian
rhythm of kisspeptin expression is largely estrogen depen-
dent, with estrogen stimulating both transcription of and
GnRH responsiveness to kisspeptin, whereas GnRH neu-
rons have a time-specific sensitivity to arginine vasopres-
sin and kisspeptin (68). Estrogenic stimulation, time
gating, and additional circadian signaling from the supra-
chiasmatic nucleus coalesce to control preovulatory LH
surge timing (69, 70), triggering ovulation. The lack of
normally occurring LH surges induced by AVPV rAAV-
kisspeptin-AS supports the role of AVPV kisspeptin in
coordinating surge timing. In contrast, the normal tem-
poral occurrence of the AVPV-intact, ARC rAAV-kiss-
peptin-AS LH surges suggests ARC kisspeptin has no in-
fluence over thisAVPVcircadian function, in linewith our
previous findings (27).
Because the only LH surge to occur in the AVPV group
was of normal amplitude but the ARC rAAV-kisspep-
tin-AS LH surges were all attenuated, we may infer that
ARC kisspeptin has an amplificatory role in surge gener-
ation. Rodent ARC KNDy projections extend to GnRH
neurons at the median eminence (21, 71, 72) and perhaps
also to an ill-defined point along the dendron projection
(73). Knocking down ARC kisspeptin may inhibit this
amplification and thus surge amplitude, through a more
general disturbance of GnRH neuron activity and hence
gonadotrophic hormone support to the ovary. Indeed, se-
lectiveARCKNDyneuron ablationmarkedly reduced cir-
culating levels of LH in OVX rats (74). It is of note that in
the present study, we did not observe a significant change
inARC-NKBcontent after knockdownof kisspeptin, thus
making it unlikely that the phenotype observed reflects
altered action of NKB on gonadotropin release. Although
previously we did not find attenuation of the estradiol-
induced LH surge using this knockdown method in adult
ovariectomized rats (27), ARC kisspeptin knockdown in
the juveniles did significantly reduce proestrous estradiol
levels by approximately 30%. These data raise the ques-
tion whether the attenuated LH surge amplitude after
ARC kisspeptin knockdown could be related to the lower
levels of estradiol extant at proestrus in these animals
rather than simply a direct effect of ARC Kiss1 per se on
the GnRH/LH surge process. It would be of interest in
future work to analyze the FOS expression of ARC kiss-
peptin neurons during the LH surge as well as to use intra-
ARCkisspeptin antagonists to seewhether these LH surge
findings are duplicated because a previous study has
tended to focus on the AVPV when analyzing LH surges.
An additional follow-up study using concomitant ARC
andAVPV rAAV-kisspeptin-AS to seewhether the impact
upon LH surges and cyclicity is compounded would also
be of interest because recent general kisspeptin knock-
down studies havemeasured basal LH but not specifically
LH surges and pulses (13, 14, 52–54).
ARC rAAV-kisspeptin-AS modestly but significantly
extended the interpulse interval in the now OVX adult
rats, decreasing LH pulse frequency as described previ-
ously (27). Monitoring of LH pulse frequency in the
KNDy neuron ablation model of Mittelman-Smith (74)
would be an intriguing follow-up study. Changes in LH
pulse frequencywere not foundafterAVPVantisense kiss-
peptin, in line with the classically distinct role of ARC and
notAVPVkisspeptin inGnRH/LHpulse regulation across
many species (75–77).The remainingARCkisspeptinmay
be insufficient for maintaining adequate folliculogenesis
and gonadotropin secretion, and this may underlie the
reduced circulating levels of estradiol and attenuated LH
surges. Kisspeptin mRNA and immunoreactivity within
the ARC decrease after acute inflammation (78), during
lactation (21), and under stress, and this is associatedwith
a decreased LH pulse frequency (79), whichwould reduce
the likelihood of pregnancy in potentially injurious con-
ditions. A comparable ARC kisspeptin reduction is re-
ported herein and also by Beale et al (27), which may
support this theory.
Our data fit well with the developing rodent KNDy-
GnRH dendronmode, which has shown that pulsed ARC
KNDy neuron kisspeptin acting throughKiss1r onGnRH
dendrons is crucial for GnRH pulse generation, although
it is probably not the pulse generator per se (19, 73) be-
cause the electrical recording of ARC kisspeptin/KNDy
neuronal activity revealed the majority to be silent or to
fire irregularly (80, 81) and no kisspeptin neurons spon-
taneously burst fire ex vivo, thought to underlie neuro-
peptide release (82). KNDyneuronsmay instead comprise
a major amplifier of GnRH dendron autonomous pulse
generation.
In conclusion, we have shown that a relatively modest
37% reduction in AVPV kisspeptin delayed puberty onset
and significantly impaired LH surges and estrous cycles,
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whereas a comparable reduction in ARC kisspeptin does
not impact on pubertal timing but significantly impairs
LH pulsatility, attenuates LH surge production, and im-
pairs estrous cyclicity. These resultsmight suggest that the
role of AVPV kisspeptin in the control of pubertal timing
is particularly sensitive to perturbation. Our findings sup-
port the classical division between ARC and AVPV in the
control of LH pulses and surges distinctly, with the added
caveat that ARC kisspeptin may have a novel amplifica-
tory role in LH surge production. Both ARC and AVPV
kisspeptins appear important for maintaining normal es-
trous cyclicity. As we have concluded previously (27), it
seems that kisspeptin expression must be kept within a
fairly narrow range to maintain normal fertility as well as
achieve timely puberty.
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